Olaf Mundigl
Roche (Switzerland)(CH)Laboratoire d'Innovation Thérapeutique(FR)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Cellular transport and secretion, Immunotherapy and Immune Responses, CAR-T cell therapy research, Lipid Membrane Structure and Behavior
Most-Cited Works
- → The synaptic vesicle cycle: a single vesicle budding step involving clathrin and dynamin.(1996)428 cited
- → A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals.(1996)411 cited
- → Preclinical Activity of the Type II CD20 Antibody GA101 (Obinutuzumab) Compared with Rituximab and Ofatumumab In Vitro and in Xenograft Models(2013)353 cited
- → Synaptic vesicle dynamics in living cultured hippocampal neurons visualized with CY3-conjugated antibodies directed against the lumenal domain of synaptotagmin(1995)295 cited
- → Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies(2011)228 cited
- → Tetanus toxin-mediated cleavage of cellubrevin impairs exocytosis of transferrin receptor-containing vesicles in CHO cells.(1994)226 cited